JPH04360834A - Keratotic reproduction inhibitor - Google Patents

Keratotic reproduction inhibitor

Info

Publication number
JPH04360834A
JPH04360834A JP13783091A JP13783091A JPH04360834A JP H04360834 A JPH04360834 A JP H04360834A JP 13783091 A JP13783091 A JP 13783091A JP 13783091 A JP13783091 A JP 13783091A JP H04360834 A JPH04360834 A JP H04360834A
Authority
JP
Japan
Prior art keywords
keratotic
plugs
keratotic plugs
acid
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13783091A
Other languages
Japanese (ja)
Other versions
JP3084085B2 (en
Inventor
Michiyo Ikeda
池田 美千代
Tomohiro Uemura
植村 智浩
Masanori Tanahashi
昌則 棚橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP03137830A priority Critical patent/JP3084085B2/en
Publication of JPH04360834A publication Critical patent/JPH04360834A/en
Application granted granted Critical
Publication of JP3084085B2 publication Critical patent/JP3084085B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a keratotic reproduction inhibitor capable of delaying production of keratotic plugs in contracted skin pores after removing the keratotic plugs, keeping also the reproduced keratotic plugs small and thereby making the skin pores inconspicuous. CONSTITUTION:A keratotic reproduction inhibitor is obtained by including 0.01-10wt.%, especially 0.1-5wt.% one or more compounds selected from tannic acid, zinc oxide, zinc sulfate, zinc chloride, potassium aluminum sulfate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum or allantoin dihydroxyaluminum as an active ingredient. The aforementioned inhibitor is capable of suppressing reproducition of keratotic plugs in temporarily contracted skin pores after removing the keratotic plugs and making the skin pores inconspicuous. Furthermore, the keratotic plugs can effectively be removed by employing a keratoric removing agent containing a polymeric compound having salt-forming groups such as carboxyl group, sulfonate group, sulfate group, phosphate residue, nitrate residue, amino group or ammonium group.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は毛穴の角栓除去後、角栓
の再生を抑制する角栓再生抑制剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a keratotic plug regeneration inhibitor that inhibits the regeneration of keratotic plugs after removal of keratotic plugs from pores.

【0002】0002

【従来の技術及び発明が解決しようとする課題】最近の
女性の肌の悩みで、上位を占めるものの一つとして毛孔
の目立ちが挙げられる。この原因としては、毛孔に形成
される角栓に起因するところが大きい。角栓は皮脂と共
に汚れを含んで角化して毛孔につまったものであり、こ
れを放置することは、毛孔の目立ちのみならず、肌の種
々のトラブルをひき起こす。従って、角栓を除去するこ
とが、美容上及び肌の健康上好ましい。
[Prior Art and Problems to be Solved by the Invention] One of the most common skin concerns faced by women these days is the visibility of pores. This is largely due to the keratotic plugs that form in the pores. A keratin plug contains sebum and dirt, turns into a keratin, and becomes clogged in the pores, and if left untreated, it not only makes the pores more noticeable, but also causes various skin problems. Therefore, it is preferable to remove the keratotic plug from the viewpoint of beauty and skin health.

【0003】しかしながら、角栓は一度の除去のみでは
不十分である。すなわち、角栓を除去した後の毛穴は、
除去後1〜2日目には、いったん小さくなるが、10日
〜2週間程度で角栓が再生して毛穴は、もとの大きさに
戻ってしまう。
[0003] However, removing the keratotic plug only once is not sufficient. In other words, the pores after removing the keratin plug are
The size of the keratin plug temporarily decreases within 1 to 2 days after removal, but within 10 days to 2 weeks, the keratin plug regenerates and the pore returns to its original size.

【0004】これに対し、毛穴を引き締め、毛穴を目立
ちにくくするという化粧水が市販されているが、角栓の
再生防止に対しては、ほとんど効果がないものである。 従って、角栓の再生を有効に抑制することのできる角栓
再生抑制剤が望まれていた。
[0004] On the other hand, lotions are available on the market that tighten pores and make them less noticeable, but they have almost no effect on preventing the regeneration of keratin plugs. Therefore, there has been a desire for an inhibitor of keratotic plug regeneration that can effectively suppress the regeneration of keratotic plugs.

【0005】[0005]

【課題を解決するための手段】斯かる実状に鑑み本発明
者は鋭意研究を行なった結果、タンニン酸等を一定量含
有する角栓再生抑制剤が、角栓除去後の一時的に収縮し
た毛穴に再び角栓が生成するのを抑制し、毛穴の目立ち
を少なくすることを見出し本発明を完成した。
[Means for Solving the Problems] In view of the above-mentioned circumstances, the present inventor conducted intensive research and found that a keratotic plug regeneration inhibitor containing a certain amount of tannic acid etc. temporarily contracted after removal of the keratotic plug. The present invention was completed by discovering that the re-generation of keratin plugs in pores can be suppressed and the pores can be made less conspicuous.

【0006】すなわち本発明は、タンニン酸、酸化亜鉛
、硫酸亜鉛、塩化亜鉛、硫酸アルミニウムカリウム、ク
ロルヒドロキシアルミニウム、アラントインクロルヒド
ロキシアルミニウム及びアラントインジヒドロキシアル
ミニウムより選ばれる1種又は2種以上を含有すること
を特徴とする角栓再生抑制剤を提供するものである。
[0006] That is, the present invention includes one or more selected from tannic acid, zinc oxide, zinc sulfate, zinc chloride, potassium aluminum sulfate, aluminum chlorohydroxy, aluminum allantoin chlorohydroxy, and aluminum aluminum allantoin dihydroxy. The present invention provides a characteristic keratotic plug regeneration inhibitor.

【0007】ここで用いるタンニン酸は、m−ガロイル
没食子酸を意味し、植物から抽出されたタンニンの加水
分解によって得られる。斯かるタンニン酸としては、精
製されたものを用いてもよいが、タンニンの加水分解物
をそのまま用いることもできる。本発明の角栓再生抑制
剤中へのタンニン酸等の配合量は0.01〜10重量%
(以下、単に「%」で示す)であるが、特に0.1 〜
5%とすることが好ましい。0.01%より少ないと角
栓再生抑制効果が十分でなく、これが10%を超えて用
いても効果にあまり差がないので好ましくない。
[0007] Tannic acid as used herein means m-galloyl gallic acid, which is obtained by hydrolysis of tannins extracted from plants. As such tannic acid, purified tannic acid may be used, but tannin hydrolyzate may also be used as it is. The amount of tannic acid etc. contained in the keratotic plug regeneration inhibitor of the present invention is 0.01 to 10% by weight.
(hereinafter simply indicated as "%"), but in particular 0.1 to
It is preferable to set it to 5%. If it is less than 0.01%, the effect of suppressing the regeneration of keratotic plugs will not be sufficient, and if it is used in excess of 10%, there will not be much difference in the effect, which is not preferable.

【0008】本発明の角栓再生抑制剤には、上記必須成
分の他に通常の化粧料に用いられる成分を必要に応じて
配合してもよい。この成分としては、水、エタノール、
多価アルコール、水溶性高分子、塩、塩基、酸、香料、
色素、防腐剤、紫外線吸収剤、金属キレート剤、油剤、
界面活性剤、ビタミン、美肌成分、殺菌剤、消炎剤、粘
度調整剤、可溶化剤等が挙げられる。
[0008] In addition to the above-mentioned essential ingredients, the keratotic plug regeneration inhibitor of the present invention may optionally contain ingredients used in ordinary cosmetics. These ingredients include water, ethanol,
Polyhydric alcohols, water-soluble polymers, salts, bases, acids, fragrances,
Pigments, preservatives, ultraviolet absorbers, metal chelating agents, oils,
Examples include surfactants, vitamins, skin-beautifying ingredients, bactericides, anti-inflammatory agents, viscosity modifiers, solubilizers, and the like.

【0009】本発明の角栓再生抑制剤は常法により製造
され、その剤型は特に限定されず、液状、ペースト状、
粉末状、顆粒状、固形状等とすることができるが、取扱
いの面から、液状又はペースト状とすることが好ましい
The keratotic plug regeneration inhibitor of the present invention is produced by a conventional method, and its dosage form is not particularly limited, and may be liquid, paste, or
It can be in the form of powder, granules, solid, etc., but from the viewpoint of handling, it is preferably in the form of liquid or paste.

【0010】本発明の角栓再生抑制剤を使用するには、
まず毛穴につまった角栓を除去する必要がある。角栓の
除去手段は特に制限されないが、以下に記すような塩生
成基を有する高分子化合物を含有することを特徴とする
角栓除去剤を用いることにより、有効に除去することが
できる。ここで用いられる高分子化合物の塩生成基とし
ては、酸又は塩基の存在により塩を形成する基であれば
特に制限されず、アニオン性、カチオン性、両イオン性
のいずれの基であってもよい。斯かる塩生成基の具体例
としては、カルボキシル基、スルホン酸残基、硫酸残基
、リン酸残基、硝酸残基、アミノ基、アンモニウム基等
が挙げられる。これらの基は一つの化合物にて2種以上
含まれていてもよい。
[0010] To use the keratotic plug regeneration inhibitor of the present invention,
First, you need to remove the keratin plugs that are clogging your pores. The means for removing keratotic plugs is not particularly limited, but they can be effectively removed by using a keratotic plug removing agent characterized by containing a polymer compound having a salt-forming group as described below. The salt-forming group of the polymer compound used here is not particularly limited as long as it forms a salt in the presence of an acid or base, and may be any anionic, cationic, or amphoteric group. good. Specific examples of such salt-forming groups include carboxyl groups, sulfonic acid residues, sulfuric acid residues, phosphoric acid residues, nitric acid residues, amino groups, and ammonium groups. Two or more types of these groups may be contained in one compound.

【0011】また、これらの高分子化合物は水溶性であ
ることが美観上好ましいが、濁っていてもかまわない。
[0011]Although it is preferable for aesthetics that these polymer compounds be water-soluble, they may be cloudy.

【0012】斯かる高分子化合物の具体例としては天然
或いは半合成のものとしては、ムコ多糖類であるヒアル
ロン酸、ヒアルロン酸Na、コンドロイチン硫酸Na;
ヘミセルロース類であるアルギン酸、アルギン酸Na、
アルギン酸アンモニウム、カルボキシメチルセルロース
Na塩、カルボキシメチルアミロースが挙げられるが、
合成系のものがより好ましく、合成系のものとしては下
記のモノマーの1種又は2種以上を重合させたもの又は
これらのモノマーと(メタ)アクリル酸エステル、スチ
レン等のビニル系モノマーといった他の一般のモノマー
との共重合体、更にこれらの重合体の混合物が挙げられ
る。
Specific examples of such polymer compounds, natural or semi-synthetic, include mucopolysaccharides hyaluronic acid, sodium hyaluronate, and sodium chondroitin sulfate;
Hemicelluloses alginic acid, sodium alginate,
Examples include ammonium alginate, carboxymethylcellulose Na salt, and carboxymethylamylose.
Synthetic ones are more preferable, and examples of synthetic ones include those obtained by polymerizing one or more of the following monomers, or a combination of these monomers and other vinyl monomers such as (meth)acrylic acid ester and styrene. Examples include copolymers with common monomers and mixtures of these polymers.

【0013】アニオン性:アクリル酸(AA)、メタク
リル酸(MA)、マレイン酸、イタコン酸等の不飽和カ
ルボン酸モノマー又はそれらの無水物又はそれらの塩;
スチレンスルホン酸、2−アクリルアミド−2−メチル
プロパンスルホン酸(AMPS)等の不飽和スルホン酸
モノマー又はこれらの塩;ビニルホスホン酸、アシッド
・ホスホキシエチル(メタ)アクリレート等の不飽和リ
ン酸モノマー。
Anionic: unsaturated carboxylic acid monomers such as acrylic acid (AA), methacrylic acid (MA), maleic acid, itaconic acid, or their anhydrides or salts thereof;
Unsaturated sulfonic acid monomers or salts thereof such as styrene sulfonic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS); unsaturated phosphoric acid monomers such as vinylphosphonic acid and acid phosphoxyethyl (meth)acrylate.

【0014】カチオン性:ジメチルアミノエチルアクリ
レート(DMAEA )、ジメチルアミノエチルメタク
リレート(DMAEMA)、アクリルアミドプロピルト
リメチルアンモニウムクロライド(DMAPAAm )
等のジアルキルアミノ基を有する(メタ)アクリル酸エ
ステル又は(メタ)アクリルアミド類;ジメチルアミノ
スチレン(DMASt )、ジメチルアミノメチルスチ
レン(DMAMSt)等のジアルキルアミノ基を有する
スチレン類;4−ビニルピリジン、2−ビニルピリジン
等のビニルピリジン類;又はこれらのハロゲン化アルキ
ル、ハロゲン化ベンジル、アルキル若しくはアリールス
ルホン酸又は硫酸ジアルキル等の公知の四級化剤を用い
て四級化したもの。
Cationic: dimethylaminoethyl acrylate (DMAEA), dimethylaminoethyl methacrylate (DMAEMA), acrylamidepropyltrimethylammonium chloride (DMAPAAm)
(meth)acrylic acid esters or (meth)acrylamides having a dialkylamino group such as; styrenes having a dialkylamino group such as dimethylaminostyrene (DMASt) and dimethylaminomethylstyrene (DMAMSt); 4-vinylpyridine, 2 - Vinylpyridines such as vinylpyridine; or those quaternized using known quaternizing agents such as alkyl halides, benzyl halides, alkyl or arylsulfonic acids, or dialkyl sulfates.

【0015】両イオン性:N−(3−スルホプロピル)
−N−アクリロイルオキシエチル−N,N−ジメチルア
ンモニウムベタイン、N−(3−スルホプロピル)−N
−メタクリロイルアミドプロピル−N,N−ジメチルア
ンモニウムベタイン、N−(3−カルボキシメチル)−
N−メタクリロイルアミドプロピル−N,N−ジメチル
アンモニウムベタイン、N−(3−スルホプロピル)−
N−メタクリロイルオキシエチル−N,N−ジメチルア
ンモニウムベタイン、N−カルボキシメチル−N−メタ
クリロイルオキシエチル−N,N−ジメチルアンモニウ
ムベタイン。
Zwitterionic: N-(3-sulfopropyl)
-N-acryloyloxyethyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-N
-methacryloylamidopropyl-N,N-dimethylammonium betaine, N-(3-carboxymethyl)-
N-methacryloylamidopropyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-
N-methacryloyloxyethyl-N,N-dimethylammonium betaine, N-carboxymethyl-N-methacryloyloxyethyl-N,N-dimethylammonium betaine.

【0016】なお、これらの高分子化合物の塩生成基が
イオン化されていない場合は、既存の酸、例えば塩酸、
硫酸等の無機塩;酢酸、プロピオン酸、乳酸、コハク酸
、グリコール酸等の有機酸、又は塩基、例えばトリメチ
ルアミン、トリエチルアミン等の三級アミン類;アンモ
ニア、水酸化ナトリウム等により中和等し、イオン化す
ることが好ましい。
[0016] If the salt-forming groups of these polymer compounds are not ionized, existing acids such as hydrochloric acid,
Inorganic salts such as sulfuric acid; organic acids such as acetic acid, propionic acid, lactic acid, succinic acid, and glycolic acid; or bases, such as tertiary amines such as trimethylamine and triethylamine; neutralized with ammonia, sodium hydroxide, etc., and ionized. It is preferable to do so.

【0017】また、これらの高分子化合物の分子量は、
1万〜150万の範囲のものが好ましく、特に10万〜
100万のものが好ましい。分子量が1万未満であると
、造膜したフィルムの強度が不十分で、皮膚に対する緊
張感が弱くなり、剥離時に破れ易くなり、一方150万
を超えるものの製造は難しい。
[0017] Furthermore, the molecular weight of these polymer compounds is
Those in the range of 10,000 to 1,500,000 are preferred, particularly 100,000 to 1,500,000.
One million is preferred. If the molecular weight is less than 10,000, the strength of the formed film will be insufficient, the tension on the skin will be weak, and it will be easy to tear when peeled off, while on the other hand, it will be difficult to produce a film with a molecular weight of more than 1,500,000.

【0018】この角栓除去剤に用いる上記高分子化合物
の配合量は0.01〜70%、特に5〜40%とするこ
とが好ましい。
The amount of the above-mentioned polymer compound used in this keratotic plug remover is preferably 0.01 to 70%, particularly 5 to 40%.

【0019】上記の合成高分子化合物は、溶剤に溶解せ
しめて使用されるが、この溶剤としては、該高分子化合
物を安定に溶解でき更に皮膚に安全なものであれば特に
限定されず、例えば水、エタノール、イソプロピルアル
コール(IPA)等が挙げられる。この溶剤の配合量は
、高分子化合物、任意成分、剤型により適宜決定すれば
よいが、一般的には30〜99.99 %、特に60〜
95%が好ましい。
The above-mentioned synthetic polymer compound is used after being dissolved in a solvent, but the solvent is not particularly limited as long as it can stably dissolve the polymer compound and is safe for the skin, such as Examples include water, ethanol, isopropyl alcohol (IPA), and the like. The blending amount of this solvent may be appropriately determined depending on the polymer compound, optional components, and dosage form, but it is generally 30 to 99.99%, particularly 60 to 99.99%.
95% is preferred.

【0020】また角栓除去剤の剤型は、パック剤の他、
綿布、スフ布、テトロン、ナイロン等の織布又はプラス
チックシート等に塗り、パップ剤としてもよい。
[0020] In addition to the pack agent, the dosage form of the keratotic plug remover is
It may be applied to cotton cloth, soft cloth, woven cloth such as Tetoron, nylon, or plastic sheet, and used as a poultice.

【0021】この角栓除去剤の製造は、通常のパック剤
やパップ剤の製造方法に準じて行なうことができる。更
にこの角栓除去剤を用いて、角栓を除去する方法は、通
常のパック剤、パップ剤の使用方法と同様にすればよい
。すなわち、例えばパック剤の場合、皮膚に塗布し、乾
燥後ピールオフすればよい。
[0021] This keratotic plug remover can be produced in accordance with the manufacturing method of ordinary packs and poultices. Furthermore, the method for removing keratotic plugs using this keratotic plug remover may be the same as the method for using ordinary packs and poultices. That is, for example, in the case of a pack agent, it may be applied to the skin, dried and then peeled off.

【0022】[0022]

【発明の効果】本発明の角栓再生抑制剤を用いれば、角
栓除去後の毛穴に再び、角栓が生成するのを遅らせるこ
とができ、また再生する角栓も小さく保つことができる
。従って、毛穴を目立たなくすることができる。
[Effects of the Invention] By using the keratotic plug regeneration inhibitor of the present invention, it is possible to delay the regeneration of keratotic plugs in the pores after removal of the keratotic plugs, and it is also possible to keep the regenerated keratotic plugs small. Therefore, pores can be made less noticeable.

【0023】[0023]

【実施例】以下、実施例を挙げて本発明を更に詳細に説
明するが、本発明はこれに限定されるものではない。 実施例1 男女3名ずつ計6名のパネラーの鼻部の両側にp−スチ
レンスルホン酸ナトリウム/メタクリル酸(1/1)共
重合体20%水溶液を0.1ml ずつほぼ均一に塗布
し、乾燥後剥離し角栓を除去した。ついで、各々鼻部の
一方にはタンニン酸1%水溶液を0.1ml ずつ塗布
し、もう一方はブランクとした。タンニン酸の塗布は朝
と晩、1日2回行ない、これを3日行なった。
[Examples] The present invention will be explained in more detail below with reference to Examples, but the present invention is not limited thereto. Example 1 0.1 ml of a 20% aqueous solution of sodium p-styrene sulfonate/methacrylic acid (1/1) copolymer was applied almost uniformly to both sides of the nose of a total of six panelists, three men and three women, and dried. After exfoliation, the keratotic plug was removed. Next, 0.1 ml of a 1% aqueous tannic acid solution was applied to one side of each nose, and the other side was left blank. Tannic acid was applied twice a day, in the morning and at night, for 3 days.

【0024】角栓除去直後と3日後の毛穴の面積を下記
測定法により測定した。結果を表1に示す。 角栓生成率測定法:同一毛穴を測定するためにあらかじ
め撮影した臨床写真と照らし合わせながら、観察する毛
穴を決定し、2mm四方の枠を貼って200倍のDSA
 (ダイレクトスキンアナライザー:花王(株)製)で
観察した。このDSA 像を画像解析することによって
、角栓除去処理直後、角栓が抜けた毛穴数と3日後、角
栓が再生している毛穴数を測定し、次式(1)により角
栓生成率を求めた。なお、毛穴は1人片側30個ずつ測
定し、個々に平均値をとり表1に示した。
[0024] Immediately after the removal of the keratotic plug and 3 days later, the area of the pore was measured using the following measuring method. The results are shown in Table 1. Measurement method for keratin plug formation rate: Determine the pore to be observed by comparing it with a clinical photograph taken in advance to measure the same pore, paste a 2 mm square frame, and measure the DSA at 200x magnification.
(Direct Skin Analyzer: manufactured by Kao Corporation). By image analysis of this DSA image, the number of pores from which keratin plugs have come out immediately after the keratin plug removal treatment and the number of pores where keratin plugs have regenerated after 3 days are measured, and the keratin plug generation rate is calculated using the following formula (1). I asked for In addition, 30 pores were measured on each side of each person, and the average value was taken for each individual and is shown in Table 1.

【0025】[0025]

【数1】[Math 1]

【0026】[0026]

【表1】[Table 1]

【0027】実施例2    角栓除去後のケア剤(リ
キットタイプ):                          
                         
                (%)  タンニン
酸                        
                         
  1.5  ソルビット             
                         
             2.0  グリセリン  
                         
                        3
.0  ポリオキシエチレンオレイルエーテル(20E
.O.)                 1.0 
 エタノール                   
                         
      15.0  香料           
                         
                     0.2 
 精製水                     
                         
        バランス量
Example 2 Care agent after removal of keratotic plug (liquid type):

(%) Tannic acid

1.5 Sorbit

2.0 Glycerin

3
.. 0 Polyoxyethylene oleyl ether (20E
.. O. ) 1.0
ethanol

15.0 Fragrance

0.2
purified water

balance amount

【0028】実施例3  
  角栓除去後のケア剤(クリームタイプ):
Example 3
Care agent after removing keratotic plug (cream type):

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】  タンニン酸、酸化亜鉛、硫酸亜鉛、塩
化亜鉛、硫酸アルミニウムカリウム、クロルヒドロキシ
アルミニウム、アラントインクロルヒドロキシアルミニ
ウム及びアラントインジヒドロキシアルミニウムより選
ばれる1種又は2種以上を含有することを特徴とする角
栓再生抑制剤。
[Claim 1] Containing one or more selected from tannic acid, zinc oxide, zinc sulfate, zinc chloride, potassium aluminum sulfate, aluminum chlorohydroxy, aluminum allantoin chlorhydroxy, and aluminum dihydroxy allantoin. Keratin plug regeneration inhibitor.
JP03137830A 1991-06-10 1991-06-10 Keratin plug regeneration inhibitor Expired - Fee Related JP3084085B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03137830A JP3084085B2 (en) 1991-06-10 1991-06-10 Keratin plug regeneration inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03137830A JP3084085B2 (en) 1991-06-10 1991-06-10 Keratin plug regeneration inhibitor

Publications (2)

Publication Number Publication Date
JPH04360834A true JPH04360834A (en) 1992-12-14
JP3084085B2 JP3084085B2 (en) 2000-09-04

Family

ID=15207839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03137830A Expired - Fee Related JP3084085B2 (en) 1991-06-10 1991-06-10 Keratin plug regeneration inhibitor

Country Status (1)

Country Link
JP (1) JP3084085B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637606A (en) * 1994-06-10 1997-06-10 Matsumoto; Toshihiro Hair grower based on allantoin or derivatives thereof
WO1997027837A1 (en) * 1996-02-02 1997-08-07 Slavko Dokmann New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637606A (en) * 1994-06-10 1997-06-10 Matsumoto; Toshihiro Hair grower based on allantoin or derivatives thereof
WO1997027837A1 (en) * 1996-02-02 1997-08-07 Slavko Dokmann New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use

Also Published As

Publication number Publication date
JP3084085B2 (en) 2000-09-04

Similar Documents

Publication Publication Date Title
US6306382B1 (en) Keratotic plug remover
US5221533A (en) Skin lotion composition
US4147782A (en) Pharmaceutical detergent composition
KR101508168B1 (en) Keratotic plug regrowth inhibition agent, keratotic plug regrowth inhibition method, and keratotic plug regrowth inhibition kit
AU707853B2 (en) Dermatological preparation and method for treating actinic keratoses
EP0826364A2 (en) Keratotic plug remover
JP3084086B2 (en) Keratin plug regeneration inhibitor
JP2002080401A (en) Gel composition for external preparation
JP2509894B2 (en) Detergent composition
JPH10298026A (en) Pack material
KR20010023182A (en) Cleansing compositions
JP2920443B2 (en) Keratin plug remover
JPH04360834A (en) Keratotic reproduction inhibitor
JP5400196B2 (en) Square plug regeneration inhibitor
JP2003226636A (en) Weak-acidic cleansing preparation
JP3455120B2 (en) Pack cosmetics
JP3578776B2 (en) Square plug removal method
WO1999038473A2 (en) Cosmetic product kit
JP3238789B2 (en) Alkaline perm solution
JP2003238341A (en) Skin care preparation
JPH07187985A (en) Skin-beautifying agent consisting essentially of phytic acid or its salts
JPH08169809A (en) Film type pack
JP3592999B2 (en) Square plug remover
JP2001220341A (en) Cosmetic and method of its use
JP2004285036A (en) Skin conditioning agent

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080630

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090630

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees